Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy
- 16 December 2015
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 22 (4) , 464-471
Abstract
This study aims to determine the risk factors for epileptogenesis and characteristics of seizures in patients with progressive multifocal leukoencephalopathy (PML) who survive more than 1 year from onset of neurological symptoms (PML survivors). We reviewed clinical data including seizure history and MR imaging studies from PML survivors evaluated at our institution between 1997 and 2014. PML progressors who passed away within 1 year and patients with a history of seizures prior to PML diagnosis were excluded from the analysis. Of 64 PML survivors, 28 (44 %) developed seizures. The median time from the onset of PML symptoms to the first seizure was 5.4 months (range 0–159) and 64 % of patients with seizures had them within the first year. The presence of juxtacortical PML lesions was associated with a relative risk of seizures of 3.5 (p < 0.02; 95 % confidence interval (CI) 1.3–9.4) in multivariate analyses. Of all seizure types, 86 % were focal and 60 % most likely originated from the frontal lobes. Among seizure patients, 89 % required treatment, including one (54 %), two (25 %), or three (10.5 %) antiepileptic drugs. Seizures are a frequent complication in PML and can develop throughout the entire course of the disease. However, late onset seizures did not signify PML relapse. Seizures may require treatment with multiple antiepileptic medications and are a significant co-morbidity in PML.Keywords
Funding Information
- National Institutes of Health (R01 074409)
- National Institutes of Health (R01 047029)
- National Institutes of Health (R01 074995)
This publication has 40 references indexed in Scilit:
- ILAE Official Report: A practical clinical definition of epilepsyEpilepsia, 2014
- Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current eraEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- Safe Treatment of Seizures in the Setting of HIV/AIDSCurrent Treatment Options in Neurology, 2013
- PML diagnostic criteriaNeurology, 2013
- Metabolic profile of PML lesions in patients with and without IRISNeurology, 2012
- Frequent Infection of Cortical Neurons by JC Virus in Patients With Progressive Multifocal LeukoencephalopathyJournal of Neuropathology & Experimental Neurology, 2012
- Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control studyAIDS Research and Therapy, 2011
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 casesThe Lancet Neurology, 2010
- Increased Propensity to Seizures After Chronic Cortical Deafferentation In VivoJournal of Neurophysiology, 2006
- PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AFTER INITIATION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN A CHILD WITH ADVANCED HUMAN IMMUNODEFICIENCY VIRUS INFECTION:A CASE OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROMEThe Pediatric Infectious Disease Journal, 2004